Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Kadiyala Venkata Ravindra
Professor of Surgery
Surgery, Abdominal Transplant Surgery
kadiyala.ravindra@duke.edu
330 Trent Dr Room 217, Box 3512, Durham, NC 27710
Research
More About This Person
glance {hide_children: true, active: false, enabled: true}
At a Glance
credentials {hide_children: true, active: false, enabled: true}
Credentials
Education
academic-experience {hide_children: true, active: false, enabled: true}
Academic Experience
Current Appointments & Affiliations
Previous Appointments & Affiliations
expertise {hide_children: true, active: false, enabled: false}
Expertise
research {hide_children: false, active: true, enabled: true}
Research
Selected Grants
publications {hide_children: true, active: false, enabled: true}
Publications
Selected Publications
artistic-works {hide_children: true, active: false, enabled: false}
Artistic Works / Events
teaching {hide_children: true, active: false, enabled: false}
Teaching
advising-mentoring {hide_children: true, active: false, enabled: false}
Advising & Mentoring
recognition {hide_children: true, active: false, enabled: false}
Recognition
professional-activities {hide_children: true, active: false, enabled: false}
Professional Activities
Manage Profile
Embed Profile Data
Manage Profile
Embed Profile Data
Selected Grants
BESTOW AT-1501-K209 Pro00116051
Clinical Trial
Principal Investigator ·
Awarded by Eledon Pharmaceuticals, Inc. ·
2024 - 2035
BESTOW: A Phase 2, Multicenter, Randomized, Open-Label Study to Evaluate the Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation
Clinical Trial
Principal Investigator ·
Awarded by Eledon Pharmaceuticals, Inc. ·
2023 - 2033
Talaris Therapeutics - FCR001A2301 FREEDOM-1 Study
Clinical Trial
Principal Investigator ·
Awarded by Talaris Therapeutics ·
2019 - 2023
Phase2 Prospective, Multi-center, Open-label, Controlled Trial to Assess the Safety and Efficacy of Cellular Immunotherapy with MDR-103 for Induction of Mixed Chimerism and Immune Tolerance in Past Recipients of HLA Zero-mismatch, Living Donor Kid
Clinical Trial
Principal Investigator ·
Awarded by Medeor Therapeutics, Inc ·
2018 - 2021
A Phase 3 prospective, randomized, multicenter, open-label, controlled trial to assess the efficacy and safety of cellular immunotherapy with MDR-101 for induction of immune tolerance in recipients of HLA-Matched, living donor kidney transplants
Clinical Trial
Principal Investigator ·
Awarded by Medeor Therapeutics, Inc ·
2018 - 2021
Prospective, Randomized, Controlled, Multicenter, Multi-National, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLASTTM Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries
Clinical Trial
Principal Investigator ·
Awarded by Biom'Up ·
2016 - 2017
